Omada Health CEO sells 17,258 OMDA shares

Omada Health, Inc. Chief Executive Officer Sean P. Duffy reported open-market sales of an aggregate 17,258 shares of Common Stock on June 24–26, 2026.

Rhea-AI Filing Summary

Omada Health, Inc. Chief Executive Officer Sean P. Duffy reported open-market sales of an aggregate 17,258 shares of Common Stock on June 24–26, 2026. The reported sale prices ranged from $19.0033 to $20.9000 per share.

After these transactions, Duffy directly holds 394,603 shares of Omada Health common stock. In addition, 851,659 shares are held in family trusts for the benefit of his family members, and he disclaims beneficial ownership of those shares except to the extent of his pecuniary interest. The filing notes that the sales were made pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2026.

Insider Trade Summary 10b5-1

Net Seller: 17,258 shares

Net Sell 5 txns

Insider Duffy Sean P.

Role Chief Executive Officer

Sold 17,258 shs ($342K)

Type	Security	Shares	Price	Value
Sale	Common Stock	9,844	$19.6072	$193K
Sale	Common Stock	4,314	$20.90	$90K
Sale	Common Stock	300	$19.0033	$6K
Sale	Common Stock	2,800	$19.0139	$53K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 394,603 shares (Direct); Common Stock — 851,659 shares (Indirect, See footnote)

Footnotes (4)

1. F1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
2. F2. This transaction was executed in multiple trades at prices ranging from $19.00 to $19.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
3. F3. This transaction was executed in multiple trades at prices ranging from $19.00 to $19.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
4. F4. Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.

Key Figures

Total shares sold: 17,258 shares Highest sale price: $20.9000 per share Other sale price: $19.6072 per share +2 more

5 metrics

Total shares sold 17,258 shares Aggregate open-market sales June 24–26, 2026

Highest sale price $20.9000 per share Common Stock sale on June 26, 2026

Other sale price $19.6072 per share Common Stock sale on June 26, 2026

Direct holdings after transactions 394,603 shares Common Stock directly owned following latest sale

Family trust holdings 851,659 shares Common Stock held in family trusts with beneficial ownership disclaimed

Key Terms

Rule 10b5-1 trading plan, open-market sale, pecuniary interest, family trusts, +1 more

5 terms

Rule 10b5-1 trading plan financial

"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

pecuniary interest financial

"disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein."

family trusts financial

"Held in family trusts for the benefit of the Reporting Person's family members."

beneficial ownership financial

"The Reporting Person disclaims beneficial ownership of the shares held by the family trusts"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Omada Health (OMDA) report for CEO Sean P. Duffy?

Omada Health reported that CEO Sean P. Duffy sold 17,258 shares of common stock in open-market transactions. These sales occurred between June 24 and June 26, 2026, at prices around $19–$21 per share, according to the Form 4 filing.

At what prices did Omada Health (OMDA) CEO Sean P. Duffy sell shares?

Sean P. Duffy’s reported sales occurred at prices from $19.0033 to $20.9000 per share. Several trades were executed in multiple lots, with weighted-average prices disclosed and detailed trade data available upon request as noted in the filing footnotes.

How many Omada Health (OMDA) shares does CEO Sean P. Duffy hold after the reported sales?

After the reported transactions, Sean P. Duffy directly holds 394,603 shares of Omada Health common stock. The Form 4 also reports 851,659 additional shares held in family trusts, for which he disclaims beneficial ownership except for his pecuniary interest.

Were Sean P. Duffy’s Omada Health (OMDA) share sales made under a Rule 10b5-1 plan?

Yes. The filing states that the transactions were made pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2026. Such plans pre-schedule trades, providing structure for insiders to transact shares over time under predefined instructions.

What does the Form 4 say about Omada Health (OMDA) shares held in family trusts?

The Form 4 reports 851,659 Omada Health shares held in family trusts for the benefit of Sean P. Duffy’s family members. He disclaims beneficial ownership of these trust-held shares except to the extent of his pecuniary interest in them.

How many Omada Health (OMDA) shares did CEO Sean P. Duffy sell in total in this Form 4?

The transaction summary shows that Sean P. Duffy sold a total of 17,258 shares of Omada Health common stock. All reported dispositions were open-market sales of non-derivative common stock, with no option exercises or derivative transactions disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/26/2026 - 07:35 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Duffy Sean P.

(Last) (First) (Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD., SUITE 120

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/24/2026		S(1)		2,800	D	$19.0139(2)	409,061	D
Common Stock	06/25/2026		S(1)		300	D	$19.0033(3)	408,761	D
Common Stock	06/26/2026		S(1)		9,844	D	$19.6072	398,917	D
Common Stock	06/26/2026		S(1)		4,314	D	$20.9	394,603	D
Common Stock								851,659	I	See footnote(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

2. This transaction was executed in multiple trades at prices ranging from $19.00 to $19.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

3. This transaction was executed in multiple trades at prices ranging from $19.00 to $19.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

4. Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.

	/s/ Nathan Salha, as Attorney-in-Fact for Sean P. Duffy	06/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)